Research Progress in the Preparation Technology of Radium-223
223Ra is a low toxicity substance α Radiotherapy nuclide, which can be used to treat castrated resistant prostate cancer (CRPC) with symptoms of bone metastasis and no visceral metastasis, was the first approved alpha therapy radiopharmaceutical on the market. In 2013, with the launch of Xofigo (223...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Board of Journal of Isotopes
2025-04-01
|
| Series: | Journal of Isotopes |
| Subjects: | |
| Online Access: | https://tws.xml-journal.net/article/doi/10.7538/tws.2023.youxian.119 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|